CHA Biotech Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 26,369.61 million compared to KRW 24,141.25 million a year ago. Net income was KRW 4,885.45 million compared to net loss of KRW 5,620.09 million a year ago.

Basic earnings per share from continuing operations was KRW 87 compared to basic loss per share from continuing operations of KRW 100 a year ago. Diluted earnings per share from continuing operations was KRW 74. Basic earnings per share was KRW 87 compared to basic loss per share of KRW 100 a year ago.

Diluted earnings per share was KRW 74.